HeartBeam
Open
$0.87
Prev. Close
$0.87
High
$0.87
Low
$0.86
Market Snapshot
$29.63M
-1.4
-0.74
16
HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. The company is headquartered in Santa Clara, California and currently employs 16 full-time employees. The company went IPO on 2021-10-14. The firm focuses on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. The company is engaged in the development of higher resolution ECG solutions is achieved through the development of the Company’s proprietary and patented electrocardiography technology platform. The company is developing three-dimensional (3D) representations of cardiac electrical activity by displaying the spatial locations of ECG waveforms. The company is developing its own product, the HeartBeam System. The HeartBeam System comprises a credit card sized 12-lead output electrocardiogram device, a patient application, a physician portal, and powerful cloud-based algorithms. The core technology consists of a series of patented inventions that allow it to capture the heart’s electrical activity from three distinct directions.
emptyResult
HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. The company is headquartered in Santa Clara, California and currently employs 16 full-time employees. The company went IPO on 2021-10-14. The firm focuses on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. The company is engaged in the development of higher resolution ECG solutions is achieved through the development of the Company’s proprietary and patented electrocardiography technology platform. The company is developing three-dimensional (3D) representations of cardiac electrical activity by displaying the spatial locations of ECG waveforms. The company is developing its own product, the HeartBeam System. The HeartBeam System comprises a credit card sized 12-lead output electrocardiogram device, a patient application, a physician portal, and powerful cloud-based algorithms. The core technology consists of a series of patented inventions that allow it to capture the heart’s electrical activity from three distinct directions.
Recently from Cashu
HeartBeam Innovates Cardiac Care with New Funding and Cable-Free ECG Technology
HeartBeam Advances Cardiac Care with Innovative Technology and Funding Initiatives HeartBeam, Inc., a pioneering medical technology firm dedicated to transforming cardiac care, recently announces a pu…
HeartBeam Submits FDA Application for Innovative 12-Lead ECG Synthesis Software in Cardiac Monitoring
HeartBeam Advances Cardiac Monitoring with FDA Submission HeartBeam, Inc., a medical technology firm based in Santa Clara, California, has taken a significant step toward revolutionizing cardiac monit…
HeartBeam Secures FDA Clearance for Innovative Arrhythmia Assessment Technology
HeartBeam Receives FDA Clearance for Innovative Arrhythmia Assessment System HeartBeam, Inc., a trailblazer in medical technology based in Santa Clara, California, recently secures 510(k) clearance fr…
HeartBeam Leads Telehealth Revolution in Cardiac Diagnostics with Innovative Remote Monitoring Solutions
HeartBeam's Innovative Approach to Cardiac Diagnostics: A New Era in Telehealth HeartBeam, a pioneer in cardiac health technology, continues to revolutionize how heart conditions are diagnosed and mon…